<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/119C5534-C0BC-4310-8481-C7E06B395A08"><gtr:id>119C5534-C0BC-4310-8481-C7E06B395A08</gtr:id><gtr:name>General Electric (GE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/40C9799D-310C-40D8-BF9F-BCC65A035F0A"><gtr:id>40C9799D-310C-40D8-BF9F-BCC65A035F0A</gtr:id><gtr:name>Philips Healthcare</gtr:name><gtr:address><gtr:line1>The Observatory</gtr:line1><gtr:line2>Castlefield Road</gtr:line2><gtr:postCode>RH2 0FY</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>School of Health Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/119C5534-C0BC-4310-8481-C7E06B395A08"><gtr:id>119C5534-C0BC-4310-8481-C7E06B395A08</gtr:id><gtr:name>General Electric (GE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/40C9799D-310C-40D8-BF9F-BCC65A035F0A"><gtr:id>40C9799D-310C-40D8-BF9F-BCC65A035F0A</gtr:id><gtr:name>Philips Healthcare</gtr:name><gtr:address><gtr:line1>The Observatory</gtr:line1><gtr:line2>Castlefield Road</gtr:line2><gtr:postCode>RH2 0FY</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7067796F-8A93-4C9A-A034-5FC55BC8720D"><gtr:id>7067796F-8A93-4C9A-A034-5FC55BC8720D</gtr:id><gtr:name>icoMetrix</gtr:name><gtr:address><gtr:line1>Tervuusesteeenweg 244</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B224E6AB-7A83-4025-87B7-DF42769CC88C"><gtr:id>B224E6AB-7A83-4025-87B7-DF42769CC88C</gtr:id><gtr:name>Dementias Neurodegen Network DeNDRoN</gtr:name><gtr:address><gtr:line1>Room B209, Clinical Sciences Building</gtr:line1><gtr:line2>Salford Royal Hospital</gtr:line2><gtr:line3>Stott Lane</gtr:line3><gtr:postCode>M6 8HD</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E9C787-1A64-4626-9702-3BA402E2D8CB"><gtr:id>C1E9C787-1A64-4626-9702-3BA402E2D8CB</gtr:id><gtr:name>Siemens Public Limited Company</gtr:name><gtr:address><gtr:line1>Sir Williams Siemens House</gtr:line1><gtr:line2>Princess Road</gtr:line2><gtr:postCode>M20 2UR</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BCAE40A9-5A38-4B94-A742-AEDAD7D4681F"><gtr:id>BCAE40A9-5A38-4B94-A742-AEDAD7D4681F</gtr:id><gtr:name>Leiden University Medical Centre</gtr:name><gtr:address><gtr:line1>PO Box 9600</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>NL-2300 RC</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F18FA757-E0BF-4938-85FF-F1FF1DE55D4B"><gtr:id>F18FA757-E0BF-4938-85FF-F1FF1DE55D4B</gtr:id><gtr:name>Philips Healthcare</gtr:name><gtr:address><gtr:line1>Philips Centre, Guildford Business Park</gtr:line1><gtr:postCode>GU2 8HX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/575583D4-06E1-47DB-9EB6-9D5FE4875E37"><gtr:id>575583D4-06E1-47DB-9EB6-9D5FE4875E37</gtr:id><gtr:name>Bioxydyn Limited</gtr:name><gtr:address><gtr:line1>Rutherford House
Pencroft Way</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M15 6SZ</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BD250DEA-56CF-4166-AF0A-87FF46CFE895"><gtr:id>BD250DEA-56CF-4166-AF0A-87FF46CFE895</gtr:id><gtr:firstName>Alistair</gtr:firstName><gtr:surname>Burns</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/20E7CBC8-0336-48E6-B199-76F5B2FDB0C0"><gtr:id>20E7CBC8-0336-48E6-B199-76F5B2FDB0C0</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Matthews</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0BDD3DA2-42AD-4773-B6FB-C16D7D53A22D"><gtr:id>0BDD3DA2-42AD-4773-B6FB-C16D7D53A22D</gtr:id><gtr:firstName>Geoff</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Parker</gtr:surname><gtr:orcidId>0000-0003-2934-2234</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D198AA54-9F54-4FF0-A45A-226FC45111FF"><gtr:id>D198AA54-9F54-4FF0-A45A-226FC45111FF</gtr:id><gtr:firstName>Karl</gtr:firstName><gtr:surname>Herholz</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02FDDA4D-0DBD-4584-911B-C60B86F8E45F"><gtr:id>02FDDA4D-0DBD-4584-911B-C60B86F8E45F</gtr:id><gtr:firstName>Herve</gtr:firstName><gtr:surname>Boutin</gtr:surname><gtr:orcidId>0000-0002-0029-5246</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1B546CBB-104F-49FF-BBAA-A0241395182B"><gtr:id>1B546CBB-104F-49FF-BBAA-A0241395182B</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Michelle</gtr:otherNames><gtr:surname>Parkes</gtr:surname><gtr:orcidId>0000-0001-6488-507X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/35002C74-4D51-47C0-B07E-5D49F542B446"><gtr:id>35002C74-4D51-47C0-B07E-5D49F542B446</gtr:id><gtr:firstName>Marie-Claude</gtr:firstName><gtr:surname>Asselin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DD273593-1D6E-492D-8E50-FFC6D2D2E976"><gtr:id>DD273593-1D6E-492D-8E50-FFC6D2D2E976</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Ross</gtr:otherNames><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FM005909%2F1"><gtr:id>EE14DB25-F340-4187-A9C2-BCE58BFF8132</gtr:id><gtr:title>Quantification of vascular and neuronal pathology in dementia using PET and MRI</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/M005909/1</gtr:grantReference><gtr:abstractText>The increasing occurrence of dementia within our ageing population is one of the pressing challenges facing society. Successful management of patients with dementia is significantly aided by early and accurate diagnosis. Imaging methods such as magnetic resonance imaging (MRI) and positron emission tomography (PET) are already used in the diagnostic process; we believe that there is substantial scope for both methods to be improved to provide more precise and sensitive diagnostic information, and to do so in a way that is easily tolerated by patients. If we are correct in this belief, then the methods we develop within this project will not only help in early diagnosis, but may also help in the discovery of new therapies and in the longer term with helping doctors select the best therapeutic strategies for patients with different forms of dementia.

Imaging methods such as MRI and PET can tell us a lot more about brains than simply providing a picture of brain shape and size. We will focus on improving MRI and PET to be sensitive to two important microscopic aspects of dementia. Firstly, we will develop and validate new methods for measuring the loss of brain cells due to the condition; this loss is the cause of many of the symptoms of dementia, such as memory problems, and we hope to be able to detect these changes earlier than has previously been possible. Secondly we will develop and validate new methods for measuring changes in blood delivery to the brain and how this can affect oxygen delivery. These changes are thought to be part of one of the important processes involved in causing cell death and tissue loss, and are likely to be particularly relevant to vascular dementia.

We will also spend considerable time checking that the measurements we develop are both accurate and practical for application in dementia patients in the future. We will optimise the way in which the scanning processes take place so that the time required for patients to lie in the scanner(s) is minimised. This will be important for future adoption of these methods in the clinical environment.</gtr:abstractText><gtr:potentialImpactText>The outputs of this research will benefit a range clinical and industrial sectors. The obvious clinical benefit is for neurology and gerontology, where the methods provided by this work will add to the toolkit available to clinicians to aid diagnosis and patient monitoring. Industrial beneficiaries are likely to include scanner manufacturers, such as Philips, Siemens (see letters of support) and GE, who are the major manufacturers of both PET and MRI scanners; more efficient and informative imaging methods are likely to increase demand for imaging equipment. The emerging field of PET+MRI hybrid systems is also likely to benefit from our work, which explicitly aims to maximise the combined information obtainable when these two modalities are used closely together. Imaging contract research, equipment and software companies also stand to benefit indirectly from our research (see letters of support from SMEs Icometrix and Bioxydyn), as we expect better imaging techniques to lead to more clinical trials of new therapies for dementia. The pharmaceutical industry will be the main industrial beneficiary of those trials; it will exploit better imaging methods to shorten trials and/or to run trials with fewer patients, as the effects of new drugs will be more readily apparent with more specific and sensitive imaging tools.

Ultimately the highest benefit of our proposed work will be felt by dementia patients and society at large. The pressing need for action on dementia within our ageing population highlights the need for earlier and more precise diagnosis. In time, patients will be provided with more appropriate treatments for their condition due to better diagnosis, and that treatment will start earlier; both factors are likely to have a significant impact on wellbeing by slowing disease progression. Healthcare systems will benefit from substantial cost savings by being able to treat earlier and more precisely, as the more severe (and costly to manage) symptoms of dementia are delayed and reduced due to better clinical decision making enabled by better diagnosis.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1099974</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration on phantoms for diffusion and perfusion MRI</gtr:description><gtr:id>BE9AE071-E3AC-41F6-AE3E-54A9EAE66E79</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:outcomeId>56b5f7f8164e61.57665431-1</gtr:outcomeId><gtr:partnerContribution>Development of models of DWI signal in the presence of diffusion and perfusion; histological validation.</gtr:partnerContribution><gtr:piContribution>Production of electrospun phantoms for diffusion and perfusion MRI</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>General Electric (GE)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>General Healthcare</gtr:department><gtr:description>Development of MR-PET methods</gtr:description><gtr:id>1144A79A-ECC5-4113-9202-D9CFBBF5600C</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>56b61474b2a742.13050287-1</gtr:outcomeId><gtr:partnerContribution>Implementation on GE MR-PET systems</gtr:partnerContribution><gtr:piContribution>New MRI and PET methods</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Philips Healthcare</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Development of MRI methods</gtr:description><gtr:id>B897960D-551D-4126-86D1-D39F5CEFAD94</gtr:id><gtr:impact>Conference proceedings and journal publications</gtr:impact><gtr:outcomeId>56b6140ab97269.19909827-1</gtr:outcomeId><gtr:partnerContribution>Implementation of the methods on Philips scanners</gtr:partnerContribution><gtr:piContribution>New MRI methods</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F62BAC8C-E3FB-42B3-ACCA-43139BD5CB7C</gtr:id><gtr:title>Quantification of GABA, glutamate and glutamine in a single measurement at 3&amp;nbsp;T using GABA-edited MEGA-PRESS.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351e6c17d21749bbe143c195e6466847"><gtr:id>351e6c17d21749bbe143c195e6466847</gtr:id><gtr:otherNames>Sanaei Nezhad F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>5aa549adbcdda4.72047253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>130FB170-554F-4974-A872-093B278453F7</gtr:id><gtr:title>Determination of Microvascular Parameters from Diffusion-Weighted Images</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ca63480a6cb7f1569c0064358da2b7"><gtr:id>f7ca63480a6cb7f1569c0064358da2b7</gtr:id><gtr:otherNames>Loughnan RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56b60db4b197d2.42610910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C20CE9B-0DA1-4912-9E26-B0A5C701A7C2</gtr:id><gtr:title>Accuracy and robustness of image-derived input functions (IDIF) for preclinical PET imaging assessed using a dynamic 3D printed phantom</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6962b920934eb02ad221b8f97d4c01e5"><gtr:id>6962b920934eb02ad221b8f97d4c01e5</gtr:id><gtr:otherNames>Asselin MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58bc1a64ab4421.92610311</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>887BE416-E06E-4C68-B339-1C25A871665A</gtr:id><gtr:title>Standardisation and quantification of 23Na-MRI: repeatability and reproducibility of sodium imaging across two independent sites</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2921d8e67ad18442d0fe3f88e2d912e"><gtr:id>f2921d8e67ad18442d0fe3f88e2d912e</gtr:id><gtr:otherNames>McHugh DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56b60c863bdbb4.37527409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76C3FA99-69D5-410A-82E6-019B60ADA0A7</gtr:id><gtr:title>Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d14875a2a0fca4c4f5d25818490f870a"><gtr:id>d14875a2a0fca4c4f5d25818490f870a</gtr:id><gtr:otherNames>Alsop DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>54634ad8abb664.89135046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7718E54-7E7A-4FC6-AB6C-4E3067DA23E1</gtr:id><gtr:title>Quantification of GABA, Glutamate and Glutamine in a single Measurement at 3 T using GABA-optimized MEGA-PRESS</gtr:title><gtr:parentPublicationTitle>NMR in Biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd15ba701769d32cad766833226a4257"><gtr:id>dd15ba701769d32cad766833226a4257</gtr:id><gtr:otherNames>Nezhad FS</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>58bc18dcdb9343.33077312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8298F083-558C-48FA-B174-136F2CB3E6E8</gtr:id><gtr:title>Determination of Microvascular Parameters from Diffusion-Weighted Images</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ca63480a6cb7f1569c0064358da2b7"><gtr:id>f7ca63480a6cb7f1569c0064358da2b7</gtr:id><gtr:otherNames>Loughnan RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bc1b128c9577.16879067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6319DCD-34FC-4745-A3BF-2181F5183542</gtr:id><gtr:title>Patch-Based Super-Resolution of MR Spectroscopic Images: Application to Multiple Sclerosis.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1326cbdc2b06cce80aa05967777ed537"><gtr:id>1326cbdc2b06cce80aa05967777ed537</gtr:id><gtr:otherNames>Jain S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn><gtr:outcomeId>5aa7d5ab1ddcf0.94936436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B37DF777-6E43-4FC4-9BAB-358CC1D92E0C</gtr:id><gtr:title>Estimation of Water Exchange across the Blood Brain Barrier Using Contrast-Enhanced ASL</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/038abb3b4d6d2d0b659df0dab5ebba08"><gtr:id>038abb3b4d6d2d0b659df0dab5ebba08</gtr:id><gtr:otherNames>Beaumont H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bc1aae755653.81338175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFF56E69-399C-4BF2-9C3D-067F72805003</gtr:id><gtr:title>Generation and validation of image-derived input functions from rodents using a dynamic 3D printed phantom</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6962b920934eb02ad221b8f97d4c01e5"><gtr:id>6962b920934eb02ad221b8f97d4c01e5</gtr:id><gtr:otherNames>Asselin MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bc1ccf821773.78468741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FEB1009-E28A-4718-8D2C-EAD3BBFDF5F8</gtr:id><gtr:title>A graded tractographic parcellation of the temporal lobe.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e00a6b0afd7111b1b8f075c3f7ae5f98"><gtr:id>e00a6b0afd7111b1b8f075c3f7ae5f98</gtr:id><gtr:otherNames>Bajada CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5aa6588b42cf12.10919371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F36C25-1DF2-4EB0-95E7-173F039223B3</gtr:id><gtr:title>Assessing Inflammation in Acute Intracerebral Hemorrhage with PK11195 PET and Dynamic Contrast-Enhanced MRI.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimaging : official journal of the American Society of Neuroimaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f292f85cf70dc97c5b7b1f59819204b6"><gtr:id>f292f85cf70dc97c5b7b1f59819204b6</gtr:id><gtr:otherNames>Abid KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1051-2284</gtr:issn><gtr:outcomeId>5aa656f1e7cbf4.63706688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C2C97F3-79F8-4211-98D9-05AC2B8E3624</gtr:id><gtr:title>Characterisation of Trans-Endothelial Water Exchange and Vessel Architecture Using Contrast-Enhanced Mri in a Transgenic Rat Model of Alzheimer's Disease</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20b5dbc818297193d1fe328c4e1431a1"><gtr:id>20b5dbc818297193d1fe328c4e1431a1</gtr:id><gtr:otherNames>Dickie BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58bc19f9f0ad18.03424591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14A69690-F020-4123-A108-BBD9AE63B9AC</gtr:id><gtr:title>Standardisation and Quantification of 23na-Mri:Repeatability and Reproducibility of Sodium Imaging across Two Independent Sites</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2921d8e67ad18442d0fe3f88e2d912e"><gtr:id>f2921d8e67ad18442d0fe3f88e2d912e</gtr:id><gtr:otherNames>McHugh DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bc1c2b4a7498.05094290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>047258DE-2112-4398-9778-5DD1B26CEB18</gtr:id><gtr:title>Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b57098bfbb5d46311f5cf2667486f3c0"><gtr:id>b57098bfbb5d46311f5cf2667486f3c0</gtr:id><gtr:otherNames>Al-Bachari S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>58c7d5d4df5084.71765585</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/M005909/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>EFFEC6B1-6BC8-4C9D-9D77-02CEF5E4E301</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biomedical neuroscience</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>